Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Nov 01 04:00PM ET
40.47
Dollar change
+0.55
Percentage change
1.38
%
IndexRUT P/E- EPS (ttm)-6.32 Insider Own3.29% Shs Outstand75.71M Perf Week-0.69%
Market Cap3.16B Forward P/E- EPS next Y-3.98 Insider Trans-0.88% Shs Float74.40M Perf Month14.42%
Income-479.52M PEG- EPS next Q-1.52 Inst Own103.82% Short Float6.26% Perf Quarter30.55%
Sales900.45M P/S3.50 EPS this Y36.47% Inst Trans-6.44% Short Ratio7.01 Perf Half Y22.60%
Book/sh-12.75 P/B- EPS next Y25.21% ROA-29.47% Short Interest4.66M Perf Year119.35%
Cash/sh14.02 P/C2.89 EPS next 5Y-9.51% ROE- 52W Range17.53 - 43.40 Perf YTD46.84%
Dividend Est.- P/FCF- EPS past 5Y-24.94% ROI- 52W High-6.75% Beta0.63
Dividend TTM- Quick Ratio2.17 Sales past 5Y29.08% Gross Margin71.23% 52W Low130.86% ATR (14)1.85
Dividend Ex-Date- Current Ratio2.23 EPS Y/Y TTM25.01% Oper. Margin-21.37% RSI (14)55.96 Volatility4.15% 5.28%
Employees995 Debt/Eq- Sales Y/Y TTM9.98% Profit Margin-53.25% Recom2.50 Target Price41.50
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q51.43% Payout- Rel Volume0.80 Prev Close39.92
Sales Surprise1.87% EPS Surprise-15.19% Sales Q/Q-12.68% EarningsNov 07 AMC Avg Volume664.89K Price40.47
SMA202.57% SMA5010.34% SMA20024.81% Trades Volume528,736 Change1.38%
Date Action Analyst Rating Change Price Target Change
Oct-10-24Resumed Raymond James Mkt Perform
Sep-04-24Initiated Robert W. Baird Outperform $44
Aug-26-24Resumed UBS Buy $47
May-20-24Upgrade Raymond James Underperform → Mkt Perform
Dec-19-23Downgrade Morgan Stanley Equal-Weight → Underweight $28
Dec-08-23Initiated Wells Fargo Overweight $37
Oct-30-23Upgrade Oppenheimer Perform → Outperform $165
Oct-27-23Downgrade Citigroup Neutral → Sell $29 → $17
Oct-06-23Downgrade Truist Buy → Hold $45 → $25
Sep-18-23Downgrade Citigroup Buy → Neutral $55 → $28
Nov-01-24 06:06AM
Oct-30-24 07:00AM
Oct-25-24 04:30PM
Oct-24-24 07:00AM
Oct-18-24 03:01PM
07:04AM Loading…
07:04AM
06:30AM
Oct-17-24 10:01AM
Oct-14-24 04:30PM
Oct-09-24 05:54PM
03:07PM
Oct-08-24 08:00AM
Oct-04-24 05:17AM
Oct-01-24 09:00AM
05:00AM
08:00AM Loading…
Sep-26-24 08:00AM
Sep-12-24 04:30PM
Aug-28-24 04:30PM
Aug-19-24 03:33PM
Aug-08-24 05:15PM
04:09PM
04:01PM
Aug-06-24 09:15AM
Jul-30-24 08:00AM
Jul-25-24 04:30PM
10:02AM
Jul-01-24 08:00AM
Jun-28-24 04:08PM
08:53AM
07:49AM
06:00AM Loading…
06:00AM
Jun-24-24 04:44AM
Jun-21-24 04:30PM
Jun-20-24 08:19AM
06:30AM
Jun-04-24 06:00AM
May-29-24 08:00AM
May-28-24 08:30AM
May-25-24 02:41AM
May-21-24 12:26PM
10:34AM
May-20-24 04:05PM
12:36PM
12:20PM
08:57AM
08:45AM
07:45AM
May-14-24 09:10AM
08:51AM
08:26AM
07:30AM
May-02-24 08:00AM
May-01-24 02:45PM
Apr-30-24 12:25PM
Apr-29-24 06:11AM
Apr-26-24 03:57PM
11:16AM
07:11AM
03:35AM
Apr-25-24 08:56PM
08:00PM
05:39PM
04:53PM
04:05PM
Apr-23-24 04:30PM
Apr-18-24 10:01AM
Apr-11-24 08:00AM
Mar-28-24 08:30AM
Mar-25-24 10:00AM
Mar-20-24 02:00PM
Mar-19-24 07:30AM
Mar-02-24 08:56AM
Mar-01-24 06:51AM
Feb-29-24 06:00PM
05:20PM
04:33PM
04:30PM
04:05PM
Feb-27-24 05:20PM
Feb-26-24 09:16AM
Feb-22-24 04:30PM
Feb-15-24 08:00AM
Feb-13-24 10:00AM
Feb-11-24 01:45AM
Jan-26-24 04:06PM
11:45AM
10:18AM
Jan-25-24 04:51PM
04:20PM
04:05PM
Jan-24-24 07:02PM
Jan-12-24 01:02AM
Jan-08-24 09:26AM
Jan-03-24 08:00AM
Dec-20-23 09:41AM
Dec-15-23 05:01PM
Dec-14-23 04:30PM
Dec-05-23 04:15PM
Nov-14-23 03:58PM
Nov-03-23 04:30PM
PTC Therapeutics, Inc. is a biopharmaceutical company, which focuses on the discovery, development, and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. The company was founded by Allan Steven Jacobson and Stuart Walter Peltz on March 31, 1998 and is headquartered in Warren, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Gravier PierreCHIEF FINANCIAL OFFICERJul 16 '24Sale34.022,26977,20053,531Jul 18 05:20 PM
ZELDIS JEROME BDirectorMay 22 '24Option Exercise26.4220,000528,40034,500May 24 05:20 PM
ZELDIS JEROME BDirectorMay 22 '24Sale38.2420,000764,80014,500May 24 05:20 PM
Golden Lee ScottEVP & CHIEF MEDICAL OFFICERMay 07 '24Sale32.821755,74459,813May 08 05:20 PM
Klein Matthew B.CHIEF EXECUTIVE OFFICERApr 19 '24Sale24.893,36183,669225,807Apr 22 05:20 PM
Pauwels EricCHIEF EXECUTIVE OFFICERApr 17 '24Sale25.1478719,78167,694Apr 19 05:20 PM
Klein Matthew B.CHIEF EXECUTIVE OFFICERApr 17 '24Sale25.141,30732,851229,168Apr 19 05:20 PM
Golden Lee ScottEVP & CHIEF MEDICAL OFFICERApr 02 '24Sale28.3752614,92359,988Apr 04 05:16 PM
Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICERJan 30 '24Sale27.2561816,84161,202Feb 01 04:18 PM
Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICERJan 30 '24Sale27.25287633,706Feb 01 04:18 PM
Boulding Mark ElliottEXEC. VP AND CLOJan 30 '24Sale27.2579421,63771,189Feb 01 04:17 PM
Pauwels EricCHIEF BUSINESS OFFICERJan 30 '24Sale27.253669,97444,181Feb 01 04:16 PM
Utter Christine MarieSVP, CHIEF ACCOUNTING OFFICERJan 30 '24Sale27.253188,66635,528Feb 01 04:15 PM
Jacobson Allan StevenDirectorJan 22 '24Option Exercise27.0510,000270,50022,348Jan 24 04:30 PM
Jacobson Allan StevenDirectorJan 22 '24Sale27.3810,000273,80412,348Jan 24 04:30 PM
Utter Christine MarieSVP, FINANCE & CAOJan 09 '24Sale29.011,65347,96135,846Jan 10 04:11 PM
Utter Christine MarieSVP, FINANCE & CAOJan 08 '24Sale28.641,18834,02537,499Jan 10 04:11 PM
SCHMERTZLER MICHAELDirectorJan 08 '24Sale27.811,50041,715115,266Jan 10 04:10 PM
Pauwels EricCHIEF BUSINESS OFFICERJan 09 '24Sale29.012,06559,91644,547Jan 10 04:09 PM
Pauwels EricCHIEF BUSINESS OFFICERJan 08 '24Sale28.641,56944,93746,612Jan 10 04:09 PM
Klein Matthew B.CHIEF EXECUTIVE OFFICERJan 09 '24Sale29.015,443157,928160,475Jan 10 04:08 PM
Klein Matthew B.CHIEF EXECUTIVE OFFICERJan 08 '24Sale28.642,23764,068165,918Jan 10 04:08 PM
Golden Lee ScottCHIEF MEDICAL OFFICERJan 09 '24Sale29.011,22535,54337,914Jan 10 04:06 PM
Golden Lee ScottCHIEF MEDICAL OFFICERJan 08 '24Sale28.6477522,19639,139Jan 10 04:06 PM
Boulding Mark ElliottEXEC. VP AND CLOJan 09 '24Sale29.011,93856,23171,983Jan 10 04:04 PM
Boulding Mark ElliottEXEC. VP AND CLOJan 08 '24Sale28.641,45741,72973,921Jan 10 04:04 PM
Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICERJan 09 '24Sale29.011,52144,13261,820Jan 10 04:03 PM
Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICERJan 08 '24Sale28.641,23635,39963,341Jan 10 04:03 PM
Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICERJan 09 '24Sale29.011002,9013,734Jan 10 04:03 PM
Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICERJan 08 '24Sale28.64531,5183,834Jan 10 04:03 PM
Klein Matthew B.CHIEF EXECUTIVE OFFICERJan 05 '24Sale27.1510,107274,393168,155Jan 09 04:29 PM
Gravier PierreCHIEF FINANCIAL OFFICERDec 12 '23Buy25.817,700198,73633,700Dec 14 04:38 PM